Secretome Therapeutics

Secretome Therapeutics Appoints New Chief Medical Officer

by | Apr 23, 2025
Michelle Smith Warren, MD, is a highly experienced pharmaceutical executive with more than two decades of leadership in clinical development, translational medicine, and regulatory strategy across multiple therapeutic areas, including cell therapy, immunology, cardiovascular, and rare diseases, Secretome said.
MORE
Dallas-Based HEST Investments Leads $1.8M SPV Investment in Secretome Therapeutics
by | Sep 17, 2024
Baltimore-based Secretome has a presence at BioLabs at Pegasus Park in Dallas. The biotech company is at the forefront of developing "revolutionary solutions" aimed at harnessing the power of secretomes, naturally occurring molecules that promote healing and regeneration, HEST said.
MORE
BioNTX iC3 Summit to Fuel North Texas Life Science Ecosystem, Honor 8 Rising Stars
by | Sep 14, 2023
The North Texas bioscience organization, a driving force for growth in the regional ecosystem, will convene leaders at its flagship conference to catalyze industry opportunities, spotlight emerging companies, and make connections.

See who made this year's Rising Stars list—and how you can attend the summit.
MORE

Dallas’ Secretome Therapeutics Appoints Board Director, Assembles Clinical Advisory Board

by | Jul 20, 2023

Secretome Therapeutics, a Dallas-based biotechnology company developing first-in-class therapeutics from neonatal mesenchymal stem cells, has appointed Margot Connor to its board of directors and announced the appointment of its clinical advisory board composed of world-class clinicians and researchers in the field of heart failure.

“I have been fortunate to be part of the stem cell-based therapy evolution, and I believe secretomes are a true breakthrough in this extraordinary field,” Connor said in a statement....

MORE
Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.